Message from the Executive Director

Who’s your #NiemannPickChampion? October is Niemann-Pick Awareness Month! These next few weeks are an especially important time to tell your family stories on your experiences with Niemann-Pick Disease. Show everyone who’s your #NiemannPickChampion! There is no better time to increase awareness of Niemann-Pick Disease and to educate friends, policy makers, clinicians, and others about this rare […]
September 2022 Newsletter
News & Events > Newsletters Message from the Executive Director | Niemann-Pick Awareness Month | Community Connections Opportunities | Family Support & Medical Conference Recordings | Cyclo Therapeutics Patient Newsletter | Orphanet Publication Alert | ASMD Accelerate | LinkedIn Pulse: US Approval of Xenpozyme | CheckRare: FDA Approves Olipudase Alfa | Fundraising | Social Services […]
NNPDF Celebrates Monumental Milestone with the First U.S. Approval for ASMD

The National Niemann-Pick Disease Foundation joins with patients and families in the U.S. and the entire global Niemann-Pick community in celebrating this historic advance in research: the first-ever U.S. approval of a treatment for ASMD! For more than 20 years, NNPDF has worked to support patients and families impacted by ASMD (acid sphingomyelinase deficiency) by […]
Summer 2022 Newsletter
News & Events > Newsletters APPROVAL! Xenpozyme for Treatment of ASMD | Community Update Series: XenpozymeMessage from the Board Chair | 2022 Family Support & Medical Conference RecapNNPDF 2022 Awards | NNPDF 2022 Board of Directors | NNPDF Welcomes New Board MembersDuke-Margolis Center Webinar | ASMD Accelerate | AllStripes UpdateACT for ALS Workshop | […]
June 2022 Newsletter
News & Events > Newsletters Message from the Board Chair | 2022 Family Support & Medical ConferenceNPC Family Advisory Working Groups | NNPDF Community Survey | ASMD Community SurveyASMD Accelerate | Duke-Margolis Center Update | Milestones: Willow HemsleyINPDR Poster Presentation on NPC | Community News Updates | Clinical Trial UpdatesSurveys & Studies | Fundraising | […]
In the Spotlight with Pam Andrews

Pam Andrews Mom to Belle & Abby, NPCFirefly Fund, Co-Founder and Executive Director Tell us a bit about yourself.My name is Pam Andrews. I’m a sixth generation Texan and was born in a small town just outside of Austin called Brenham, Texas. You may have heard of it before, as it’s the home of Blue […]
May 2022 Newsletter
News & Events > Newsletters 2022 Family Support & Medical ConferenceNNPDF Cora Sterling Endurance Award | NNPDF Research Fellowship ApplicationsINPDA – ASMD Webinar Recording | ASMD Accelerate | Pfrieger’s DigestTransport NPC | Clinical Trial Updates | Community News Updates | Surveys & Studies Fundraising | Membership | Emergency Hardship Program NNPDF Family Support & […]
Message from NNPDF on arimoclomol

Dear NPC Community Members, This week, Orphazyme announced that they have reached an agreement with US-based pharma company KemPharm to acquire arimoclomol, the investigational drug candidate that Orphazyme had in development for the treatment of Niemann-Pick disease type C (NPC), which is schedule to officially to occur on June 1, 2022. Under the terms of […]
INPDA Webinar: Patient Reported Outcomes – Pediatric Experience with Olipudase alfa
Slideshow Presentation: The impacts of olipudase alfa on pediatric patients with ASMD and their families: Results of an international survey https://vimeo.com/710377598 Stay Connected. Stay Informed. Become an NNPDF member for the latest research updates, event invitations, and a direct line to the community. BECOME A MEMBER TODAY
April 2022 Newsletter
News & Events > Newsletters Message from Executive Director | 2022 Family Support & Medical ConferenceFamily Advisory Working Groups | Family Conference ScholarshipsJoele Ruppert & Joseph Colton ASMD Scholarship | NNPDF Cora Sterling Endurance AwardNNPDF Research Fellowship Applications | INPDA – ASMD Survey Webinar Community Update Webinar Series with Sanofi – Recording | In […]